These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12725947)

  • 41. Evaluation of platelet transfusion triggers in a tertiary-care hospital.
    Cameron B; Rock G; Olberg B; Neurath D
    Transfusion; 2007 Feb; 47(2):206-11. PubMed ID: 17302765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice.
    Johansson PI; Stensballe J; Rosenberg I; Hilsløv TL; Jørgensen L; Secher NH
    Transfusion; 2007 Apr; 47(4):593-8. PubMed ID: 17381616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycans and glycosylation of platelets: current concepts and implications for transfusion.
    Sørensen AL; Hoffmeister KM; Wandall HH
    Curr Opin Hematol; 2008 Nov; 15(6):606-11. PubMed ID: 18832932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing platelet transfusion therapy.
    Heal JM; Blumberg N
    Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients.
    Saigo K; Sakota Y; Masuda Y; Matsunaga K; Takenokuchi M; Nishimura K; Sugimoto T; Sakurai K; Hashimoto M; Yanai T; Hayakawa A; Takeshima Y; Nomura T; Kubota Y; Kumagai S
    Transfus Apher Sci; 2008 Apr; 38(2):127-32. PubMed ID: 18331815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.
    Osselaer JC; Doyen C; Defoin L; Debry C; Goffaux M; Messe N; Van Hooydonk M; Bosly A; Lin JS; Lin L; Corash L
    Transfusion; 2009 Jul; 49(7):1412-22. PubMed ID: 19389022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia.
    Salama A; Kiesewetter H; Kalus U; Movassaghi K; Meyer O
    Thromb Haemost; 2008 Nov; 100(5):762-5. PubMed ID: 18989518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Post-transfusional platelet increment: effect of clinical factors].
    Muggenthaler KH; Böck M; Heim MU; Mempel W
    Beitr Infusionsther Transfusionsmed; 1994; 32():467-9. PubMed ID: 9480144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trigger for platelet transfusion.
    Rebulla P
    Vox Sang; 2000; 78 Suppl 2():179-82. PubMed ID: 10938948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors affecting platelet yield and their impact on the platelet increment of patients receiving single donor PLT transfusion.
    Enein AA; Hussein EA; El Shafie S; Hallouda M
    J Clin Apher; 2007 Feb; 22(1):5-9. PubMed ID: 17266120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The level of matrix metalloproteinase-2 in donor plasma strongly correlates with post-transfusion recovery of stored platelet concentrates.
    Mutlu A; Allen DJ; Freedman J; Leytin V
    Vox Sang; 2008 Feb; 94(2):143-5. PubMed ID: 18028261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Introduction of platelet additive solution in platelet concentrates: towards a decrease of blood transfusion reactions].
    Rebibo D; Simonet M; Hauser L
    Transfus Clin Biol; 2008 Nov; 15(5):289-93. PubMed ID: 18930424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Recommendations for platelet transfusion by the Joint Thrombocyte Working Party of the German Societies of Transfusion Medicine and Immunohaematology (DGTI), Thrombosis and Haemostasis Research (GTH), and Haematology and Oncology (DGHO)].
    Greinacher A; Kiefel V; Klüter H; Kroll H; Pötzsch B; Riess H; ; ;
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2675-9. PubMed ID: 17109279
    [No Abstract]   [Full Text] [Related]  

  • 54. Volume-reduced platelet concentrates.
    Schoenfeld H; Spies C; Jakob C
    Curr Hematol Rep; 2006 Mar; 5(1):82-8. PubMed ID: 16537051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimation and predictive use of the corrected count increment--a proposed clinical guideline.
    Wood L; Jogessar V; Ward P; Jacobs P
    Transfus Apher Sci; 2005 Feb; 32(1):117-24. PubMed ID: 15737880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Survey on the threshold for platelet transfusions].
    Hiruma K; Okuyama Y; Osaka A; Kasai M; Kodo H; Takamoto S; Handa M; Fujii H; Muto Y; Mori M; Shimizu M
    Rinsho Ketsueki; 2004 Nov; 45(11):1187-92. PubMed ID: 15609685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Factors affecting posttransfusion platelet efficiency "close relationship between patient and product"].
    Sensebé L
    Transfus Clin Biol; 2007 May; 14(1):90-3. PubMed ID: 17513157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A simple automatized audit system for following and managing practices of platelet and plasma transfusions in a neonatal intensive care unit.
    Petäjä J; Andersson S; Syrjälä M
    Transfus Med; 2004 Aug; 14(4):281-8. PubMed ID: 15285724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Current status and problem of platelet transfusion for hematopoietic diseases: results from a questionnaire survey].
    Kato H; Handa M; Takamoto S
    Rinsho Ketsueki; 2006 Dec; 47(12):1514-20. PubMed ID: 17233469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients.
    Spahr JE; Rodgers GM
    Am J Hematol; 2008 Feb; 83(2):122-5. PubMed ID: 17874448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.